Loading...
ATR logo

AptarGroup, Inc.NYSE:ATR Stock Report

Market Cap US$7.4b
Share Price
US$114.18
My Fair Value
n/a
1Y-33.0%
7D-10.9%
Portfolio Value
​
View

AptarGroup, Inc.

NYSE:ATR Stock Report

Market Cap: US$7.4b

AptarGroup (ATR) Stock Overview

Designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. More details

ATR fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends5/6

Rewards

Trading at 30.6% below our estimate of its fair value

Earnings grew by 24.8% over the past year

Pays a reliable dividend of 1.68%

Risk Analysis

Significant insider selling over the past 3 months


ATR Community Fair Values

Create Narrative

See what 10 others think this stock is worth. Follow their fair value or set your own to get alerts.

ATR logo
AptarGroup

ATR: Expanded Partnership Agreements Will Drive Long-Term Healthcare Solutions

Key Takeaways Proprietary drug delivery innovations and sustainable packaging recognition are driving revenue growth, margin expansion, and strengthening competitive positioning. Strategic expansion in Asia-Pacific and operational efficiency improvements are diversifying revenues, optimizing costs, and supporting long-term market leadership.
View narrative
US$170.71
FV
33.1% undervalued intrinsic discount
6.31%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
ATR logo
AptarGroup

European Destocking And Litigation Will Mar Results But Spur Recovery

Key Takeaways Margin pressures stem from shifts in packaging trends, normalization of key pharma products, and rising legal and sustainability-related costs dampening earnings and cash flow. Exposure to intense industry competition, evolving customer demands, and increased regulatory requirements threatens AptarGroup's long-term revenue growth and profitability.
View narrative
US$153
FV
25.4% undervalued intrinsic discount
4.58%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
ATR logo
AptarGroup

Rising Global Wellness Trends Will Unlock Biologics And Smart Packaging

Key Takeaways Growing focus on innovative drug delivery and systemic nasal therapies positions AptarGroup for expanding high-margin revenue streams and strategic partnerships in pharmaceuticals. Leadership in sustainable, personalized packaging and expansion in Asian markets drives long-term growth across beauty, closures, and health segments.
View narrative
US$220
FV
48.1% undervalued intrinsic discount
6.98%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
View Stock Community

AptarGroup, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for AptarGroup
Historical stock prices
Current Share PriceUS$114.18
52 Week HighUS$178.03
52 Week LowUS$103.23
Beta0.51
1 Month Change-14.29%
3 Month Change-17.58%
1 Year Change-32.96%
3 Year Change13.78%
5 Year Change-10.52%
Change since IPO2,242.15%

Recent News & Updates

AptarGroup: Pharma Setback Creates Long-Term Opportunities

Nov 02

AptarGroup (NYSE:ATR) Is Increasing Its Dividend To $0.48

Oct 18
AptarGroup (NYSE:ATR) Is Increasing Its Dividend To $0.48

Recent updates

AptarGroup: Pharma Setback Creates Long-Term Opportunities

Nov 02

AptarGroup (NYSE:ATR) Is Increasing Its Dividend To $0.48

Oct 18
AptarGroup (NYSE:ATR) Is Increasing Its Dividend To $0.48

AptarGroup, Inc.'s (NYSE:ATR) Business Is Trailing The Market But Its Shares Aren't

Aug 28
AptarGroup, Inc.'s (NYSE:ATR) Business Is Trailing The Market But Its Shares Aren't

AptarGroup's (NYSE:ATR) Dividend Will Be $0.45

Jul 15
AptarGroup's (NYSE:ATR) Dividend Will Be $0.45

Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 28%?

Jul 02
Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 28%?

These 4 Measures Indicate That AptarGroup (NYSE:ATR) Is Using Debt Reasonably Well

Jun 19
These 4 Measures Indicate That AptarGroup (NYSE:ATR) Is Using Debt Reasonably Well

AptarGroup's (NYSE:ATR) Returns Have Hit A Wall

May 13
AptarGroup's (NYSE:ATR) Returns Have Hit A Wall

Subdued Growth No Barrier To AptarGroup, Inc.'s (NYSE:ATR) Price

Apr 30
Subdued Growth No Barrier To AptarGroup, Inc.'s (NYSE:ATR) Price

Is AptarGroup (NYSE:ATR) Using Too Much Debt?

Mar 07
Is AptarGroup (NYSE:ATR) Using Too Much Debt?

With EPS Growth And More, AptarGroup (NYSE:ATR) Makes An Interesting Case

Feb 21
With EPS Growth And More, AptarGroup (NYSE:ATR) Makes An Interesting Case

A Look At The Fair Value Of AptarGroup, Inc. (NYSE:ATR)

Feb 03
A Look At The Fair Value Of AptarGroup, Inc. (NYSE:ATR)

AptarGroup, Inc.'s (NYSE:ATR) Shares May Have Run Too Fast Too Soon

Jan 20
AptarGroup, Inc.'s (NYSE:ATR) Shares May Have Run Too Fast Too Soon

AptarGroup (NYSE:ATR) Has Some Way To Go To Become A Multi-Bagger

Dec 25
AptarGroup (NYSE:ATR) Has Some Way To Go To Become A Multi-Bagger

AptarGroup Has Gotten Too Expensive

Dec 02

These 4 Measures Indicate That AptarGroup (NYSE:ATR) Is Using Debt Reasonably Well

Nov 28
These 4 Measures Indicate That AptarGroup (NYSE:ATR) Is Using Debt Reasonably Well

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

Nov 14
Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching
User avatar

Proprietary Drug Delivery And Digital Health Innovations To Spearhead Revenue Surge

Expansion in digital health services and sustainability initiatives may enhance brand value and open up new market opportunities, driving future growth.

AptarGroup: Shares Are Pumped Up

Jul 16

AptarGroup: Exceptional Quality, But Priced For Perfection

Jan 18

Shareholder Returns

ATRUS PackagingUS Market
7D-10.9%-8.8%-2.1%
1Y-33.0%-22.6%17.2%

Return vs Industry: ATR underperformed the US Packaging industry which returned -22.4% over the past year.

Return vs Market: ATR underperformed the US Market which returned 20.1% over the past year.

Price Volatility

Is ATR's price volatile compared to industry and market?
ATR volatility
ATR Average Weekly Movement2.8%
Packaging Industry Average Movement4.0%
Market Average Movement6.5%
10% most volatile stocks in US Market17.4%
10% least volatile stocks in US Market3.0%

Stable Share Price: ATR has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: ATR's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199213,500Stephan Tandawww.aptar.com

AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions.

AptarGroup, Inc. Fundamentals Summary

How do AptarGroup's earnings and revenue compare to its market cap?
ATR fundamental statistics
Market capUS$7.42b
Earnings (TTM)US$419.39m
Revenue (TTM)US$3.66b
17.9x
P/E Ratio
2.0x
P/S Ratio

Is ATR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ATR income statement (TTM)
RevenueUS$3.66b
Cost of RevenueUS$2.27b
Gross ProfitUS$1.40b
Other ExpensesUS$976.54m
EarningsUS$419.39m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)6.39
Gross Margin38.11%
Net Profit Margin11.45%
Debt/Equity Ratio43.0%

How did ATR perform over the long term?

See historical performance and comparison

Dividends

1.7%
Current Dividend Yield
28%
Payout Ratio

Does ATR pay a reliable dividends?

See ATR dividend history and benchmarks
When do you need to buy ATR by to receive an upcoming dividend?
AptarGroup dividend dates
Ex Dividend DateOct 23 2025
Dividend Pay DateNov 13 2025
Days until Ex dividend13 days
Days until Dividend pay date8 days

Does ATR pay a reliable dividends?

See ATR dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/04 06:14
End of Day Share Price 2025/11/04 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AptarGroup, Inc. is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ghansham PanjabiBaird
Mark WildeBMO Capital Markets Equity Research
George StaphosBofA Global Research